4//SEC Filing
Guyer William 4
Accession 0001193125-25-236107
CIK 0001088856other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 5:51 PM ET
Size
8.6 KB
Accession
0001193125-25-236107
Insider Transaction Report
Form 4
Guyer William
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-07$21.65/sh+20,000$433,000→ 25,287 total - Exercise/Conversion
Stock option (right to buy)
2025-10-07−20,000→ 310,000 totalExercise: $21.65Exp: 2031-09-01→ Common Stock (20,000 underlying) - Sale
Common Stock
2025-10-07$89.94/sh−20,000$1,798,782→ 5,287 total
Footnotes (3)
- [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $89.85 to $90.18 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001879013
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 5:51 PM ET
- Size
- 8.6 KB